Kaya Q1 Results: Net loss narrows 45% QoQ, revenue rises 14%

3 min read     Updated on 03 Aug 2026, 04:34 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Kaya Limited reported a Q1FY27 net loss of ₹15.18 crore, improving from ₹27.77 crore in Q4FY26, as revenue rose 14% YoY to ₹60.14 crore. The Board approved a leadership shift: Rishabh Mariwala to become MD and Harsh Mariwala Non-Executive Chairman from November 1, 2026. New appointments include Shilpa Rathi as CS and Bindiya Varmani as VP-HR.

powered bylight_fuzz_icon
47300637

*this image is generated using AI for illustrative purposes only.

kaya reported a narrowed quarterly loss and rising revenues for the quarter ended June 30, 2026, while its Board of Directors approved a significant leadership transition set to take effect in November 2026. The company posted a standalone net loss of ₹15.18 crore (₹1517.91 lakh) for Q1FY27, down from a loss of ₹27.77 crore (₹2776.73 lakh) in the preceding quarter. Revenue from operations increased 13.9% year-on-year to ₹60.14 crore (₹6013.56 lakh), driven by growth in its skin care and hair care business segment.

The financial results were reviewed by the Audit Committee and approved by the Board on August 03, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory auditors, B S R & Co. LLP, issued an unmodified limited review report on the unaudited financial results pursuant to Regulation 33. The company continues to operate under a going concern basis, supported by financial backing from the promoter group, despite maintaining a negative net worth position as of June 30, 2026.

Leadership Transition

The Board approved a structural change in executive roles subject to shareholder approval. Mr. Harsh Mariwala, currently serving as Managing Director and Chairman, will transition to the role of Non-Executive Director and Chairman starting November 1, 2026. His current term expires on October 31, 2026. Concurrently, Mr. Rishabh Mariwala has been appointed as Managing Director (Promoter and Executive) for a five-year term from November 1, 2026, to October 31, 2031. Mr. Rishabh Mariwala is liable to retire by rotation.

Additionally, the Board appointed Mrs. Shilpa Rathi as Company Secretary and Compliance Officer, effective August 03, 2026, pursuant to Section 203 of the Companies Act, 2013. Mrs. Rathi was also designated as the Nodal Officer under the Investor Education and Protection Fund Authority Rules, 2016. Ms. Bindiya Varmani was appointed as Vice President and Head of HR, effective the same date.

Financial Performance

Revenue from operations stood at ₹60.14 crore (₹6013.56 lakh), compared to ₹52.79 crore (₹5279.22 lakh) in Q1FY26. Total income reached ₹61.27 crore (₹6127.23 lakh). Employee benefits expense remained relatively stable at ₹17.07 crore (₹1707.46 lakh), while finance costs increased slightly to ₹9.34 crore (₹933.56 lakh). Depreciation and amortisation expenses were recorded at ₹10.84 crore (₹1083.58 lakh).

Particulars Q1FY27 (₹ Lakh) Q4FY26 (₹ Lakh) Q1FY26 (₹ Lakh)
Revenue from Operations 6,013.56 5,579.92 5,279.22
Other Income 113.67 200.04 61.31
Total Income 6,127.23 5,779.96 5,340.53
Total Expenses 7,645.14 8,930.82 6,747.07
Net Loss (1,517.91) (2,776.73) (1,406.54)

What the Numbers Show

The quarter-on-quarter improvement in net loss is largely attributable to the absence of exceptional items that impacted the previous quarter. In Q4FY26, the company recognized an impact of Labour Codes amounting to ₹3.74 crore (₹374.13 lakh), which contributed significantly to the higher loss. In Q1FY27, no such exceptional items were recorded. Furthermore, the company did not recognize any impairment losses in the current quarter, unlike the ₹11.77 crore (₹1176.58 lakh) impairment loss on Property, Plant and Equipment recorded in FY26. This normalization of expenses, combined with top-line growth, resulted in a more contained bottom-line deficit.

The Board deferred the agenda item regarding the issuance of equity shares or debt securities through private placement or other modes till further notice. A revised date for the deferred board meeting will be communicated in due course. The company’s statutory auditor noted that the figures for the three months ended March 31, 2026, are balancing figures between audited full-year figures and reviewed year-to-date figures.

Historical Stock Returns for Kaya

1 Day5 Days1 Month6 Months1 Year5 Years
+0.98%-1.48%+11.97%-17.23%-33.75%-44.25%

How is the leadership transition to Rishabh Mariwala expected to influence Kaya's strategic roadmap for its skin and hair care segments over the next five years?

Given the deferred equity or debt issuance, what alternative strategies is Kaya pursuing to address its negative net worth and secure long-term capital stability?

Will the current reliance on promoter group financial backing be sufficient to sustain operations, or will Kaya need to seek external funding sources in the near term?

Kaya Ltd's Om Prakash Manchanda steps down as independent director after five-year term

1 min read     Updated on 03 Aug 2026, 10:40 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Om Prakash Manchanda ceased to be an Independent Director of Kaya Limited on August 02, 2026, after completing his first five-year term. The company filed the requisite intimation with BSE and NSE under SEBI LODR Regulation 30. The Board thanked him for his guidance and contributions during his tenure.

powered bylight_fuzz_icon
47279388

*this image is generated using AI for illustrative purposes only.

Kaya Limited has confirmed that Om Prakash Manchanda ceased to serve as an Independent Director on August 02, 2026, following the completion of his first consecutive term of five years. The departure marks the end of a significant governance cycle for the Mumbai-based wellness and healthcare services provider, with the Board of Directors formally acknowledging his tenure and contributions to the company’s strategic direction.

The intimation was issued to the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that Manchanda’s cessation is effective from the end of the day on August 02, 2026. The disclosure also references compliance with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026, ensuring all regulatory requirements for director changes are met.

Tenure and Contributions

Manchanda, identified by Director Identification Number (DIN) 02099404, served his full initial term without interruption. The Board of Directors and the Management of Kaya Limited have placed on record their sincere appreciation for his valuable guidance, support, and significant contributions during his time with the company. His exit does not appear to be linked to any controversy or performance issue, but rather represents a standard procedural conclusion of a statutory director term.

Regulatory Disclosures

The company provided specific details regarding the change in board composition in Annexure A of its exchange filing. The key particulars are outlined below:

Particulars Description
Reason for Cessation Completion of first consecutive term of five years
Date of Cessation August 02, 2026
Effective Time End of the day on August 02, 2026
DIN 02099404

The filing was digitally signed by Brijesh Goyal, Chief Financial Officer of Kaya Limited, on August 03, 2026. As per standard corporate governance practices, the company is expected to initiate the process of appointing a new Independent Director to fill the vacancy, subject to shareholder approval and regulatory norms, although no specific timeline or candidate details were disclosed in this immediate notification.

Historical Stock Returns for Kaya

1 Day5 Days1 Month6 Months1 Year5 Years
+0.98%-1.48%+11.97%-17.23%-33.75%-44.25%

What is the expected timeline for Kaya Limited to nominate and appoint a successor to fill the vacant Independent Director position?

How might the change in board composition impact Kaya Limited's strategic roadmap for its wellness and healthcare services expansion?

Are there any specific regulatory deadlines under SEBI guidelines that Kaya Limited must meet to ensure the new director is appointed without governance lapses?

More News on Kaya

1 Year Returns:-33.75%